Hcw Biologics Stock Price on September 9, 2024
| HCWB Stock | USD 0.61 0.16 20.78% |
If you're considering investing in HCW Stock, it is important to understand the factors that can impact its price. As of today, the current price of HCW Biologics stands at 0.61, as last reported on the 26th of November, with the highest price reaching 0.74 and the lowest price hitting 0.57 during the day. HCW Biologics is out of control given 3 months investment horizon. HCW Biologics holds Efficiency (Sharpe) Ratio of 0.0872, which attests that the company had a 0.0872% return per unit of volatility over the last 3 months. We are able to interpolate and break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.71% are justified by taking the suggested risk. Use HCW Biologics market risk adjusted performance of (1.47), and Semi Deviation of 7.39 to evaluate company specific risk that cannot be diversified away.
At present, HCW Biologics' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 33.9 M, whereas Total Stockholder Equity is forecasted to decline to about 12.8 M. . At present, HCW Biologics' Price To Sales Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 30.12, whereas Price Earnings Ratio is forecasted to decline to (1.86). HCW Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
HCW |
Sharpe Ratio = 0.0872
| Best Portfolio | Best Equity | |||
| Good Returns | HCWB | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 42.55 actual daily | 96 96% of assets are less volatile |
Expected Return
| 3.71 actual daily | 74 74% of assets have lower returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average HCW Biologics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HCW Biologics by adding it to a well-diversified portfolio.
Price Book 2.7998 | Enterprise Value Ebitda (3.63) | Price Sales 8.2411 | Shares Float 17.8 M | Wall Street Target Price 3 |
Related Headline
Rezolute Headline on 9th of September 2024
FDA Gives Green Signal To Rezolutes Genetic Disorder Treatme... by finance.yahoo.com
Monday, the FDA removed partial clinical holds on Rezolute, Inc.s RZ358 , a potential treatment for hypoglycemia caused by congenital hyperinsulinism . Congenital HI is a genetic disorder in which the insulin cells of the pancreas, called beta cells, secrete too much insulin. Also Read Why Is Small-Cap Metabolic-Focused Rezolute Stock Trading Higher On Wednesday Ersodetug is currently being studied in sunRIZE, a global Phase 3, multi-center, doub
HCW Biologics Valuation on September 9, 2024
It is possible to determine the worth of HCW Biologics on a given historical date. On September 9, 2024 HCW was worth 0.68 at the beginning of the trading date compared to the closed value of 0.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HCW Biologics stock. Still, in general, we apply an absolute valuation method to find HCW Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HCW Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HCW Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 0.56 | 0.70 | 0.46 | 0.70 | 79,346 | |
09/09/2024 | 0.68 | 0.68 | 0.55 | 0.55 | 37,866 |
| 0.55 | 0.57 | 0.55 | 0.56 | 6,661 |
| Backtest HCW Biologics | | | HCW Biologics History | | | HCW Biologics Valuation | Previous | Next |
HCW Biologics Trading Date Momentum on September 9, 2024
| On September 10 2024 HCW Biologics was traded for 0.56 at the closing time. The top price for the day was 0.57 and the lowest listed price was 0.55 . The trading volume for the day was 6.7 K. The trading history from September 10, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.82% . The trading delta at closing time against the current closing price is 0.00% . |
HCW Biologics Fundamentals Correlations and Trends
By evaluating HCW Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HCW Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HCW financial account trend analysis is a perfect complement when working with valuation or volatility modules.About HCW Biologics Stock history
HCW Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HCW is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HCW Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HCW Biologics stock prices may prove useful in developing a viable investing in HCW Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 35.9 M | 28.9 M | |
| Net Loss | -13.4 M | -14.1 M |
HCW Biologics Stock Technical Analysis
HCW Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
HCW Biologics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
HCW Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
HCW Biologics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how HCW Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HCW Biologics shares will generate the highest return on investment. By undertsting and applying HCW Biologics stock market strength indicators, traders can identify HCW Biologics entry and exit signals to maximize returns
HCW Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HCW Biologics' price direction in advance. Along with the technical and fundamental analysis of HCW Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HCW to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0859 | |||
| Jensen Alpha | 4.45 | |||
| Total Risk Alpha | (2.43) | |||
| Sortino Ratio | 0.4183 | |||
| Treynor Ratio | (1.48) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for HCW Stock analysis
When running HCW Biologics' price analysis, check to measure HCW Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HCW Biologics is operating at the current time. Most of HCW Biologics' value examination focuses on studying past and present price action to predict the probability of HCW Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HCW Biologics' price. Additionally, you may evaluate how the addition of HCW Biologics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |